"/> Novus Biologicals™ Peptide bloquant d’anticorps DR… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps DRAK1

Réf. : BL-RE-052144Réf. fabricant : 18280486 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
9263
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76896. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 15 amino amino terminus of human DRAK1.

Points forts

Source

Synthetic

(Accession #: Q9UEE5) The DRAK1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-052144
Réf. fabricant18280486
Gene ID (Entrez)9263
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76896. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneDAP kinase-related apoptosis-inducing protein kinase 1, DRAK1death-associated protein kinase-related 1, EC 2.7.11.1, serine/threonine kinase 17 A, serine/threonine kinase 17 A (apoptosis-inducing), serine/threonine-protein kinase 17 A
Symbole de gène(s)STK17A
Type de produitDRAK1
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne15 amino amino terminus of human DRAK1
Une question, une configuration particulière ?
Contactez-nous pour un devis.